Literature DB >> 11754357

Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.

Philip G Hargreaves1, Aymen Al-Shamkhani.   

Abstract

CD30 is an unusual member of the TNF receptor superfamily with a duplicated segment within its extracellular domain that may function as an additional ligand binding site. The extracellular domain of CD30 is shed from cells and soluble CD30 levels are elevated in certain disease states. Soluble CD30 may bind to its ligand, CD153, with high affinity and block its interaction with membrane-bound CD30. We have generated soluble recombinant forms of CD30 and CD153 in order to characterize their interaction and assess their biological activity. Soluble trimeric CD153 bound to membrane-anchored CD30 with a relatively high affinity (K(D)=23 nM) and was effective in triggering cell death and TNF-alpha production in the presence of cross-linking antibodies. The affinity and kinetics of the interaction between soluble CD30 and CD153 were determined using the BIAcore biosensor. In contrast to other members of the TNF receptor superfamily, soluble monomeric CD30 bound to its ligand with high affinity (K(D)=4.5 nM) and prevented the interaction of cellular CD153 with immobilized CD30. Furthermore, soluble CD30 blocked cell death signals generated by cell surface-expressed CD30 effectively. These data suggest that soluble CD30 may have biological functions in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754357     DOI: 10.1002/1521-4141(200201)32:1<163::AID-IMMU163>3.0.CO;2-T

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Authors:  Isabell Lang; Simone Füllsack; Agnes Wyzgol; Andrea Fick; Johannes Trebing; José Antonio Carmona Arana; Viktoria Schäfer; Daniela Weisenberger; Harald Wajant
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

2.  Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy.

Authors:  Satoshi Nagata; Tomoko Ise; Masanori Onda; Kazuyasu Nakamura; Mitchell Ho; Andrew Raubitschek; Ira H Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-19       Impact factor: 11.205

3.  A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.

Authors:  Patricia Price; Niamh M Keane; Silvia Lee; Andrew F Y Lim; Elizabeth J McKinnon; Martyn A French
Journal:  Immunology       Date:  2006-06-22       Impact factor: 7.397

Review 4.  Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.

Authors:  Michelle A Fanale; Anas Younes
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.

Authors:  Sarah L Buchan; Aymen Al-Shamkhani
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 6.  The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.

Authors:  Anna Maria Berghella; Patrizia Pellegrini; Tiziana Del Beato; Fabiana Ciccone; Ida Contasta
Journal:  Cancer Immunol Immunother       Date:  2011-07-08       Impact factor: 6.968

7.  A benchmarked protein microarray-based platform for the identification of novel low-affinity extracellular protein interactions.

Authors:  Yi Sun; Marcus Gallagher-Jones; Colin Barker; Gavin J Wright
Journal:  Anal Biochem       Date:  2012-02-17       Impact factor: 3.365

8.  A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge.

Authors:  Jonathan S Boomer; Amit D Parulekar; Brenda M Patterson; Huiqing Yin-Declue; Christine M Deppong; Seth Crockford; Nizar N Jarjour; Mario Castro; Jonathan M Green
Journal:  Allergy Asthma Clin Immunol       Date:  2013-09-17       Impact factor: 3.406

9.  Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene.

Authors:  Minhua Li; Bo Ye; Yuxia Zhang; Honglei Chen; Dong Xia; Mingqiu Liu; Fei Yang
Journal:  J Biomed Biotechnol       Date:  2009-09-24

10.  Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age.

Authors:  Anna Maria Berghella; Ida Contasta; Giuseppe Marulli; Carlo D'Innocenzo; Ferdinando Garofalo; Francesca Gizzi; Marco Bartolomucci; Giacomo Laglia; Marisa Valeri; Mario Gizzi; Mauro Friscioni; Mario Barone; Tiziana Del Beato; Enzo Secinaro; Patrizia Pellegrini
Journal:  Immun Ageing       Date:  2014-02-06       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.